» Articles » PMID: 30519263

Effects of Qianlie Tongqiao Capsule on Bladder Weight and Growth Factors in Bladder Tissue of Rats with Testosterone-Induced Benign Prostatic Hyperplasia

Overview
Date 2018 Dec 7
PMID 30519263
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Qianlie Tongqiao Capsule (QTC) is clinically confirmed to be efficacious and safe in treating lower urinary tract syndromes and bladder dysfunction that are induced by benign prostatic hyperplasia (BPH). However, the functional mechanisms of QTC remain unclear. We aim to investigate the effects of QTC on both bladder weight and several growth factors in the bladder tissue of rats with testosterone-induced BPH. BPH in the rats was established through bilateral orchiectomy and subcutaneous administration of testosterone propionate (5 mg/kg) dissolved in corn oil. At the end of the study, all bladder tissues were collected and weighed, and a histological examination was conducted using H&E staining. Immunohistochemistry and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) were applied to detect the expression of nerve growth factor (NGF), basic fibroblast growth factor (bFGF), and transformation growth factor-1 (TGF-1) in the bladder tissue. The expression of Bcl-2 and Bax in the bladder tissue was tested by Western Blot and qRT-PCR. We found that QTC, especially when administered in high-dosages, had a significant inhibitory effect on bladder weight gain and overexpression of NGF, bFGF, and TGF-1 in rats with BPH. In addition, QTC downregulated and upregulated protein and mRNA expression of Bcl-2 and Bax in the bladder after prostatic obstruction, respectively. Furthermore, QTC balanced the Bcl-2/Bax ratio. Overall, these results reveal possible functional mechanisms of QTC in treating BPH-caused bladder dysfunction, and further studies are needed.

Citing Articles

Modeling of Benign Prostatic Hyperplasia in Rats with a High Dose of Testosterone.

Sorokina I, Zhukova N, Meshkova Y, Baev D, Tolstikova T, Bakarev M Bull Exp Biol Med. 2022; 173(5):680-686.

PMID: 36210419 DOI: 10.1007/s10517-022-05613-0.

References
1.
Sun J, Shen W, An W, Li Q, Qiu S, Jiang S . A Chinese Medicine Formula "Xian-Jia-Tang" for Treating Bladder Outlet Obstruction by Improving Urodynamics and Inhibiting Oxidative Stress through Potassium Channels. Evid Based Complement Alternat Med. 2017; 2017:8147258. PMC: 5414489. DOI: 10.1155/2017/8147258. View

2.
Steers W, Kolbeck S, Creedon D, Tuttle J . Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest. 1991; 88(5):1709-15. PMC: 295710. DOI: 10.1172/JCI115488. View

3.
Chen G, Liu H, Cheng F . Fangjihuangqi tang improved lower urinary tract dysfunction in benign prostatic hyperplasia rats model. J Tradit Chin Med. 2013; 33(3):349-54. DOI: 10.1016/s0254-6272(13)60177-6. View

4.
Iguchi N, Malykhina A, Wilcox D . Inhibition of HIF Reduces Bladder Hypertrophy and Improves Bladder Function in Murine Model of Partial Bladder Outlet Obstruction. J Urol. 2016; 195(4 Pt 2):1250-6. PMC: 5505069. DOI: 10.1016/j.juro.2015.08.001. View

5.
Liu L, Wan Y, Shen A, Zhao J, Lin J, Zhong X . miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia. Evid Based Complement Alternat Med. 2015; 2015:365484. PMC: 4534592. DOI: 10.1155/2015/365484. View